+Compare
ESLOF
Stock ticker: OTC
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
90.98B

ESLOF EssilorLuxottica Forecast, Technical & Fundamental Analysis

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for ESLOF with price predictions
07:00 PM EST Dec 04, 2023

ESLOF's Stochastic Oscillator is sitting in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

ESLOF moved above its 50-day moving average on October 31, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ESLOF crossed bullishly above the 50-day moving average on November 06, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ESLOF advanced for three days, in of 188 cases, the price rose further within the following month. The odds of a continued upward trend are .

ESLOF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 217 cases where ESLOF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ESLOF moved out of overbought territory on November 16, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on November 29, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on ESLOF as a result. In of 121 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ESLOF turned negative on November 28, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESLOF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.152) is normal, around the industry mean (25.197). P/E Ratio (34.483) is within average values for comparable stocks, (79.553). Projected Growth (PEG Ratio) (3.666) is also within normal values, averaging (6.249). Dividend Yield (0.018) settles around the average of (0.019) among similar stocks. P/S Ratio (3.182) is also within normal values, averaging (44.232).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ESLOF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 3%. For the same Industry, the average monthly price growth was 9%, and the average quarterly price growth was -11%. LNDZF experienced the highest price growth at 375%, while IMMVF experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -27%. For the same stocks of the Industry, the average monthly volume growth was -17% and the average quarterly volume growth was 41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 56
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I.Advisor
published Dividends

ESLOF paid dividends on June 21, 2021

EssilorLuxottica ESLOF Stock Dividends
А dividend of $1.08 per share was paid with a record date of June 21, 2021, and an ex-dividend date of May 28, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
147, Rue de Paris
Phone
+33 149774224
Employees
190000
Web
https://www.essilorluxottica.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTHCX69.630.46
+0.67%
Fidelity Advisor® Technology C
BFTUX40.680.15
+0.37%
Baron Fifth Avenue Growth R6
EACPX48.080.15
+0.31%
Eaton Vance Tax-Managed Multi-Cap Gr A
TVDAX9.68N/A
N/A
Guggenheim RBP® Large-Cap Defensive A
ROFCX11.21-0.21
-1.84%
Royce Small-Cap Opportunity Consult

Groups containing ESLOF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOF
1D Price
Change %
ESLOF100%
+1.18%
Medical Specialties
(undefined stocks)
32%
Poorly correlated
-0.98%
Medical Specialties
(undefined stocks)
32%
Poorly correlated
-0.98%